To determine whether MIG-6 levels are correlated to P4 responsiveness in the human endometrium, we examined the expression of MIG-6 in 15 women with CAH or early-stage (stage I and II) EEC who had received P4 therapy. This evidence concerns the gene ERRFI1 and exstrophy-epispadias complex.